Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2025-01-05T12:39:48.355Z Has data issue: false hasContentIssue false
  • English
  • Français

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?

Published online by Cambridge University Press:  02 November 2007

Anne M. Dickinson ,
Jane L. Harrold  and
Hannah Cullup
Anne M. Dickinson*
Affiliation:
School of Clinical and Laboratory Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK.
Jane L. Harrold
Affiliation:
School of Clinical and Laboratory Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK.
Hannah Cullup
Affiliation:
School of Clinical and Laboratory Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK.
*
*Corresponding author: Anne Dickinson, Institute of Cellular Medicine, School of Clinical and Laboratory Sciences, Newcastle upon Tyne, NE2 4HH, UK. Tel/Fax: +44 (0)191 222 6794; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Haematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for many patients with malignant and non-malignant haematological diseases. The success of HSCT is greatly reduced by the development of complications, which include graft-versus-host disease (GVHD), relapse and infection. Human leukocyte antigen (HLA) matching of patients and donors is essential, but does not completely prevent these complications; non-HLA genes may also have an impact upon transplant outcome. Polymorphisms within genes that are associated with an individual's capability to mount an immune response to alloantigen and infectious pathogens and/or response to drugs (pharmacogenomics) are all currently being studied for their association with HSCT outcome. This review summarises the potential role of non-HLA polymorphisms in predicting HSCT outcome, from studies on retrospective transplant cohorts of HLA-identical siblings and matched unrelated donors. The clinical relevance and interpretation of non-HLA genetics, and how these could be used alongside clinical risk factors in HSCT, are also discussed.

Type
Review Article
Information
Expert Reviews in Molecular Medicine , Volume 9 , Issue 29 , November 2007 , pp. 1 - 19
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

1Petersdorf, E. et al. (2001) Genomics of unrelated-donor hematopoietic cell transplantation. Curr Opin Immunol 13, 582-589CrossRefGoogle ScholarPubMed
2Bidwell, J.L. et al. (1999) Human cytokine gene nucleotide sequence alignments: supplement 1. Eur J Immunogenet 26, 135-223CrossRefGoogle ScholarPubMed
3Bidwell, J.L. et al. (1998) Human cytokine gene nucleotide sequence alignments, 1998. Eur J Immunogenet 25, 83-265CrossRefGoogle ScholarPubMed
4Turner, D. et al. (1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779CrossRefGoogle ScholarPubMed
5Glucksberg, H. et al. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18, 295-304CrossRefGoogle Scholar
6Przepiorka, D. et al. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15, 825-828Google ScholarPubMed
7Antin, J.H. and Ferrara, J.L.M. (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood 80(12), 2964-2968CrossRefGoogle ScholarPubMed
8Krenger, W., Hill, G.R. and Ferrara, J.L. (1997) Cytokine cascades in acute graft-versus-host disease [Review]. Transplantation 64, 553-558CrossRefGoogle ScholarPubMed
9Eckmann, L. (2006) Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 22, 95-101CrossRefGoogle ScholarPubMed
10Harris, G., KuoLee, R. and Chen, W. (2006) Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J Gastroenterol 12, 2149-2160CrossRefGoogle ScholarPubMed
11Nestel, F.P. et al. (1992) Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 175, 405-413CrossRefGoogle ScholarPubMed
12Shlomchik, W.D. et al. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285, 412-415CrossRefGoogle ScholarPubMed
13Matte, C.C. et al. (2004) Donor APCs are required for maximal GVHD but not for GVL. Nature Med 10, 987-992CrossRefGoogle Scholar
14Collin, M.P. et al. (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 203, 27-33CrossRefGoogle ScholarPubMed
15Maeda, Y. et al. (2005) Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood 105, 2023-2027CrossRefGoogle ScholarPubMed
16Graubert, T.A. et al. (1997) Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 100, 904-911CrossRefGoogle ScholarPubMed
17Shulman, H.M. et al. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69, 204-217CrossRefGoogle Scholar
18Akpek, G. et al. (2003) Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 102, 802-809CrossRefGoogle ScholarPubMed
19Greinix, H.T. et al. (2007) A single-center pilot validation study of a new chronic GVHD skin scoring system. Biol Blood Marrow Transplant 13, 715-723CrossRefGoogle ScholarPubMed
20Claman, H.N. et al. (1985) Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol 94, 73-84CrossRefGoogle Scholar
21Mullighan, C.G. and Bardy, P.G. (2004) Advances in the genomics of allogeneic haemopoietic stem cell transplantation. Drug Development Research 62, 273-292CrossRefGoogle Scholar
22Lichtman, A.H., Krenger, W. and Ferrara, J.L.M. Cytokine Networks. In Graft vs Host Disease (2nd edn) (Ferrara, J. L. M., Deeg, H. J. and Burakoff, S. J., eds), pp. 179-218, Marcel DekkerGoogle Scholar
23Takahashi, H. et al. (2000) Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 26, 1317-1323CrossRefGoogle ScholarPubMed
24Wang, J. et al. (2002) [The relationship between donor TNFalpha - 308 (G/A) genotype and recipient acute GVHD in allo-BMT]. Zhonghua Xue Ye Xue Za Zhi 23, 397-399Google ScholarPubMed
25Middleton, P.G. et al. (1998) Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 92, 3943-3948CrossRefGoogle ScholarPubMed
26Socié, G. et al. (2001) Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 72, 699-706CrossRefGoogle ScholarPubMed
27Nordlander, A. et al. (2002) The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation. Br J Haematol 119, 1133-1336CrossRefGoogle ScholarPubMed
28Rocha, V. et al. (2002) Host defence and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplant. Blood 100, 3908-3918CrossRefGoogle Scholar
29Lin, M.T. et al. (2003) Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 349, 2201-2210CrossRefGoogle ScholarPubMed
30Mullighan, C. et al. (2004) Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation 77, 587-596CrossRefGoogle ScholarPubMed
31Bogunia-Kubik, K., Polak, M. and Lange, A. (2003) TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 32, 617-622CrossRefGoogle Scholar
32Nedospasov, S.A. et al. (1991) DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol 147, 1053-1059CrossRefGoogle ScholarPubMed
33Holzinger, I. et al. (1995) Cloning and genomic characterization of LST1: a new gene in the human TNF region. Immunogenetics 42, 315-322CrossRefGoogle ScholarPubMed
34Udalova, I.A. et al. (1993) Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16, 180-186CrossRefGoogle ScholarPubMed
35Pociot, F. et al. (1991) A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 33, 37-49CrossRefGoogle ScholarPubMed
36Turner, D.M. et al. (1995) A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 60, 1113-1117CrossRefGoogle ScholarPubMed
37Cavet, J. et al. (1999) Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94, 3941-3946CrossRefGoogle ScholarPubMed
38Shaw, B.E. et al. (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue antigens 63, 401-411CrossRefGoogle ScholarPubMed
39Zheng, L. et al. (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351CrossRefGoogle ScholarPubMed
40Stark, G.L. et al. (2003) Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. Transplantation 76, 1742-1749CrossRefGoogle ScholarPubMed
41Morita, C. et al. (2001) Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum 44, 2819-28273.0.CO;2-2>CrossRefGoogle ScholarPubMed
42Edwards-Smith, C.J. et al. (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30, 526-530CrossRefGoogle ScholarPubMed
43Kim, D.H. et al. (2005) IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation 79, 1615-1622CrossRefGoogle ScholarPubMed
44Seo, K.W. et al. (2005) Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant 36, 1089-1095CrossRefGoogle ScholarPubMed
45Yang, Y.G. et al. (2005) Role of interferon-gamma in GvHD and GvL. Cell Mol Immunol 2, 323-329Google ScholarPubMed
46Cavet, J. et al. (2001) Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 98, 1594-1600CrossRefGoogle ScholarPubMed
47Bogunia-Kubik, K. et al. (2005) Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Haematologica 90, 425-426Google Scholar
48Mlynarczewska, A. et al. (2004) Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 34, 339-344CrossRefGoogle ScholarPubMed
49Brok, H.P. et al. (1993) Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 151, 6451-6459CrossRefGoogle ScholarPubMed
50Bogunia-Kubik, K. et al. (2006) The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. Br J Haematol 132, 326-332CrossRefGoogle ScholarPubMed
51Cullup, H. and Stark, G. (2005) Interleukin-1 polymorphisms and graft versus host disease. Leuk Lymphoma 46, 517-523CrossRefGoogle Scholar
52Cullup, H. et al. (2001) Donor interleukin-1 receptor antagonist genotype associated with acute graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic transplants. Br J Haematol 113, 807-813CrossRefGoogle ScholarPubMed
53Cullup, H. et al. (2003) Polymorphisms of IL-1alpha constitute independent risk factors for chronic graft versus host disease following allogeneic bone marrow transplantation. Br J Haematol 122, 778-787CrossRefGoogle Scholar
54Terry, C.F., Loukaci, V. and Green, F.R. (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275, 18138-18144CrossRefGoogle ScholarPubMed
55Ferrari, S.L. et al. (2003) Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88, 255-259CrossRefGoogle ScholarPubMed
56Fishman, D. et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102, 1369-1376CrossRefGoogle Scholar
57Karabon, L. et al. (2005) IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. Hum Immunol 66, 700-710CrossRefGoogle ScholarPubMed
58Banovic, T. et al. (2005) TGF-beta in allogeneic stem cell transplantation: friend or foe? Blood 106, 2206-2214CrossRefGoogle ScholarPubMed
59Grainger, D.J. et al. (1999) Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet 8, 93-97CrossRefGoogle Scholar
60Leffell, M.S. et al. (2001) Association between TGF-beta expression and severe GVHD in allogeneic bone marrow transplantation. Transplant proceedings 33, 485-486CrossRefGoogle ScholarPubMed
61Hattori, H. et al. (2002) Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant 30, 665-671CrossRefGoogle ScholarPubMed
62Yigit, B. et al. (2006) Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. Cell Biochem Funct 25, 423-426CrossRefGoogle Scholar
63Bogunia-Kubik, K. et al. (2006) CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Haematologica 91, 1628-1634Google ScholarPubMed
64Welniak, L.A. et al. (2004) An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp Hematol 32, 318-324CrossRefGoogle ScholarPubMed
65Wysocki, C.A. et al. (2004) Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol 173, 845-854CrossRefGoogle ScholarPubMed
66Terwey, T.H. et al. (2005) CCR2 is required for CD8-induced graft-versus-host disease. Blood 106, 3322-3330CrossRefGoogle ScholarPubMed
67Faaij, C.M. et al. (2006) A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease. Br J Haematol 133, 538-549CrossRefGoogle ScholarPubMed
68Jaksch, M., Remberger, M. and Mattsson, J. (2005) Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. Biology of blood marrow transplantion 11, 280-287CrossRefGoogle ScholarPubMed
69Duffner, U. et al. (2003) Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol 31, 897-902CrossRefGoogle ScholarPubMed
70Varona, R. et al. (2005) CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. Blood 106, 18-26CrossRefGoogle ScholarPubMed
71Loeffler, J. et al. (2006) Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 44, 1847-1850CrossRefGoogle ScholarPubMed
72Xu, D., Liu, H. and Komai-Koma, M. (2004) Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol 1, 239-246Google ScholarPubMed
73Kaisho, T. and Akira, S. (2003) Regulation of dendritic cell function through toll-like receptors. Curr Mol Med 3, 759-771CrossRefGoogle ScholarPubMed
74Kaisho, T. and Akira, S. (2004) Pleiotropic function of Toll-like receptors. Microbes Infect 6, 1388-1394CrossRefGoogle ScholarPubMed
75Lorenz, E. et al. (2001) Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7, 384-387CrossRefGoogle ScholarPubMed
76Kesh, S. et al. (2005) TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann NY Acad Sci 1062, 95-103CrossRefGoogle ScholarPubMed
77Holler, E. et al. (2004) Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104, 889-894CrossRefGoogle ScholarPubMed
78Holler, E. et al. (2006) Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: Effect on long term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107, 4189-4193CrossRefGoogle ScholarPubMed
79Granell, M. et al. (2007) Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica 91, 1372-1376Google Scholar
80Mullighan, C.G. et al. (2002) Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 99, 3524-3529CrossRefGoogle ScholarPubMed
81van der Straaten, H.M. et al. (2005) The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation. Biol Blood Marrow Transplant 11, 206-212CrossRefGoogle ScholarPubMed
82Cavanagh, G. et al. (2005) Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation. Transplantation 79, 602-605CrossRefGoogle ScholarPubMed
83Behar, E. et al. (1996) Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 334, 286-291CrossRefGoogle ScholarPubMed
84Nichols, W.C. et al. (1996) Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease. Blood 88, 4429-4434CrossRefGoogle Scholar
85Grumet, F.C. et al. (2001) CD31 mismatching affects marrow transplantation outcome. Biol Blood Marrow Transplant 7, 503-512CrossRefGoogle ScholarPubMed
86Middleton, P.G. et al. (2003) Oestrogen receptor alpha gene polymorphism associates with occurrence of graft-versus-host disease and reduced survival in HLA-matched sib-allo BMT. Bone Marrow Transplant 32, 41-47CrossRefGoogle ScholarPubMed
87Middleton, P.G. et al. (2002) Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant 30, 223-228CrossRefGoogle ScholarPubMed
88Bogunia-Kubik, K. and Lange, A. (2005) HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease. Transplantation 79, 815-820CrossRefGoogle ScholarPubMed
89Keen, L.J. et al. (2004) Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 103, 3599-3602CrossRefGoogle ScholarPubMed
90Bettens, F. et al. (2006) Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantation. Transplantation 81, 1261-1267CrossRefGoogle ScholarPubMed
91Remberger, M. et al. (2003) Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation. Eur J Haematol 70, 384-391CrossRefGoogle ScholarPubMed
92Ishikawa, Y. et al. (2002) Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 29, 569-575CrossRefGoogle ScholarPubMed
93MacMillan, M.L. et al. (2003) Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. Br J Haematol 121, 597-604CrossRefGoogle ScholarPubMed
94Ferrara, J.L.M. and Deeg, H.J. (1991) Graft-versus-host disease. N Engl J Med 324, 667-674CrossRefGoogle ScholarPubMed
95MacMillan, M.L. et al. (2003) High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation 76, 1758-1762CrossRefGoogle ScholarPubMed
96Shamim, Z. et al. (2006) Genetic polymorphisms in the genes encoding human interleukin-7 receptor-alpha: prognostic significance in allogeneic stem cell transplantation. Bone Marrow Transplant 37, 485-491CrossRefGoogle ScholarPubMed
97Joshi, B.H. et al. (2006) Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Vitam Horm 74, 479-504CrossRefGoogle ScholarPubMed
98Jordan, W.J. et al. (2004) IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation. Blood 103, 717-724CrossRefGoogle ScholarPubMed
99Ohashi, J. et al. (2003) A single-nucleotide substitution from C to T at position -1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun 4, 528-531CrossRefGoogle Scholar
100Steck, A.K. et al. (2005) Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes 54, 2482-2486CrossRefGoogle ScholarPubMed
101Yang, J., Qiao, H.L. and Dong, Z.M. (2005) Polymorphisms of IL-13 and IL-4-IL-13-SNPs in patients with penicillin allergies. Eur J Clin Pharmacol 61, 803-809CrossRefGoogle ScholarPubMed
102Cardoso, S.M. et al. (2004) Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation. Br J Haematol 126, 704-710CrossRefGoogle ScholarPubMed
103Reddy, P. et al. (2003) Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood 101, 2877-2885CrossRefGoogle ScholarPubMed
104Ulrich, C.M. et al. (2001) Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 98, 231-234CrossRefGoogle ScholarPubMed
105Rocha, V. et al. (2003) Association of Pharmacogenes polymorphisms with toxicities and GvHD after HLA-identical sibling bone marrow transplantation. Blood 102, 241a; abstract 848Google Scholar
106Robien, K. et al. (2004) Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 10, 7592-7598CrossRefGoogle ScholarPubMed
107Kalayoglu-Besisik, S. et al. (2003) Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation. Transplantation 76, 1775-1777CrossRefGoogle ScholarPubMed
108Murphy, N. et al. (2006) Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate. Bone Marrow Transplant 37, 773-779CrossRefGoogle ScholarPubMed
109Kim, I. et al. (2007) Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Ann Hematol 86, 41-48CrossRefGoogle Scholar
110Anglicheau, D. et al. (2004) CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther 75, 422-433CrossRefGoogle ScholarPubMed
111Kallianpur, A.R. (2005) Genomic screening and complications of hematopoietic stem cell transplantation: has the time come? Bone Marrow Transplant 35, 1-16CrossRefGoogle ScholarPubMed
112Gratwohl, A. et al. (2002) Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 100, 3877-3886CrossRefGoogle ScholarPubMed
113Gratwohl, A. et al. (1998) Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352, 1087-1092CrossRefGoogle ScholarPubMed
114Weisdorf, D. et al. (1991) Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51, 1197-1203CrossRefGoogle ScholarPubMed
115Niederwieser, D. et al. (1989) Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplant 4, 151-156Google ScholarPubMed
116Clave, E. et al. (2005) Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 105, 2608-2613CrossRefGoogle ScholarPubMed
117Talvensaari, K. et al. (2002) A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99, 1458-1464CrossRefGoogle Scholar
118Oh, H. et al. (2005) Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 105, 1408-1416CrossRefGoogle ScholarPubMed
119Kubistova, Z. et al. (2006) Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int J Immunogenet 33, 261-267CrossRefGoogle ScholarPubMed
120Laguila Visentainer, J.E. et al. (2005) Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Cytokine 32, 171-177CrossRefGoogle Scholar
121Leisenring, W.M. et al. (2006) An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 108, 749-755CrossRefGoogle ScholarPubMed
122Ollier, W.E. (2004) Cytokine genes and disease susceptibility. Cytokine 28, 174-178CrossRefGoogle ScholarPubMed
123Colhoun, H.M., McKeigue, P.M. and Davey Smith, G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361, 865-872CrossRefGoogle ScholarPubMed
124Filipovich, A.H. et al. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11, 945-956CrossRefGoogle ScholarPubMed
125Dickinson, A.M. (2006) Biobanks and registries for HSCT research: potential for future individualized medicine. Int J Immunogenet 33, 153-154CrossRefGoogle ScholarPubMed

Further reading, resources and contacts

Schlomchik, W.D. (2007) Graft-versus-host disease. Nat Rev Immunol 7, 340-352CrossRefGoogle Scholar
Rossi, M. et al. (2005) Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 175, 1373-1381CrossRefGoogle ScholarPubMed
Wysocki, C.A. et al. (2005) Leukocyte migration and graft-versus-host disease. Blood 105, 4191-4199CrossRefGoogle ScholarPubMed
Ruggeri, L. et al. (2006) Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol Rev 214, 202-218CrossRefGoogle ScholarPubMed